1. Home
  2. BSL vs RPID Comparison

BSL vs RPID Comparison

Compare BSL & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone

BSL

Blackstone

HOLD

Current Price

$13.51

Market Cap

176.1M

Sector

Finance

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$3.11

Market Cap

178.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSL
RPID
Founded
2010
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.1M
178.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BSL
RPID
Price
$13.51
$3.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
71.9K
144.5K
Earning Date
01-01-0001
11-07-2025
Dividend Yield
9.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,523,000.00
Revenue This Year
N/A
$19.36
Revenue Next Year
N/A
$21.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.63
52 Week Low
$12.19
$0.91
52 Week High
$14.56
$4.50

Technical Indicators

Market Signals
Indicator
BSL
RPID
Relative Strength Index (RSI) 39.54 41.28
Support Level $13.50 $2.70
Resistance Level $13.59 $3.69
Average True Range (ATR) 0.08 0.24
MACD -0.00 -0.03
Stochastic Oscillator 29.31 40.91

Price Performance

Historical Comparison
BSL
RPID

About BSL Blackstone

Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: